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Background: While research continues into indicators such as preventable and amenable mortality in order to
evaluate quality, access, and equity in the healthcare, it is also necessary to continue identifying the areas of
greatest risk owing to these causes of death in urban areas of large cities, where a large part of the population is
concentrated, in order to carry out specific actions and reduce inequalities in mortality. This study describes
inequalities in amenable mortality in relation to socioeconomic status in small urban areas, and analyses their
evolution over the course of the periods 1996–99, 2000–2003 and 2004–2007 in three major cities in the Spanish
Mediterranean coast (Alicante, Castellón, and Valencia).
Methods: All deaths attributed to amenable causes were analysed among non-institutionalised residents in the
three cities studied over the course of the study periods. Census tracts for the cities were grouped into 3 socioeconomic
status levels, from higher to lower levels of deprivation, using 5 indicators obtained from the 2001 Spanish Population
Census. For each city, the relative risks of death were estimated between socioeconomic status levels using Poisson’s
Regression models, adjusted for age and study period, and distinguishing between genders.
Results: Amenable mortality contributes significantly to general mortality (around 10%, higher among men), having
decreased over time in the three cities studied for men and women. In the three cities studied, with a high degree of
consistency, it has been seen that the risks of mortality are greater in areas of higher deprivation, and that these excesses
have not significantly modified over time.
Conclusions: Although amenable mortality decreases over the time period studied, the socioeconomic inequalities
observed are maintained in the three cities. Areas have been identified that display excesses in amenable mortality,
potentially attributable to differences in the healthcare system, associated with areas of greater deprivation. Action must
be taken in these areas of greater inequality in order to reduce the health inequalities detected. The causes behind
socioeconomic inequalities in amenable mortality must be studied in depth.
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Avoidable mortality, as an indicator for the quality of
healthcare services, was first introduced by Rustein in
1976, who presented the first theoretical study on this
issue, where he proposed a list of unnecessary diseases
and disabilities or unnecessary untimely deaths, based
on the assertion that if health services had acted cor-
rectly, they would have been prevented or delayed [1].
Its definition and conceptualisation, as well as the list of
causes of death included therein, has evolved over time
adapting to medical and technological advances [2-9].
Avoidable mortality is divided into two groups, according
to the characteristics of the healthcare intervention 1)
Amenable mortality: related with secondary prevention and
directly with healthcare intervention, in other words access
to healthcare, advice, diagnosis, or treatment: and 2) Pre-
ventable mortality: related with primary prevention, lifestyle
habits, intervention programmes, etc. [10].
Given that the quality of healthcare and fair access to
it must be considered objectives of health policy, amen-
able mortality can be considered an indicator of poten-
tial weaknesses in the healthcare system, in order to
study these weaknesses in greater depth and has been
used for decades to show the positive impact of health-
care on the health of the population in many industria-
lised countries [5,11].
Studies conducted in different countries have related
certain population socioeconomic indicators with avoid-
able mortality and, in particular, with amenable, pointing
to higher mortality rates among the more underprivil-
eged groups [12-23]. These inequalities are in themselves
a risk factor for the health of the population, and they
must be studied in order to identify the most vulnerable
groups and regions, and be able to carry out specific in-
terventions [24].
In recent decades, improvements in living conditions
and growing accessibility to healthcare assistance have
led to a reduction in premature mortality and, therefore,
avoidable mortality, both amenable and preventable.
Various studies evaluating trends in avoidable mortal-
ity over time in specific regions or groups have shown
this decline [5,7,25-30]. Some studies that have linked
this temporal evolution with socioeconomic inequal-
ities have suggested that socioeconomic inequalities in
avoidable mortality have remained and even increased
in recent years [12,18,20,23,31]. Other studies that
have analysed avoidable mortality in small areas, or
which combine this analysis with a study of the associ-
ation observed with indicators of inequality, have demon-
strated an important link between the most depressed areas
and those with the highest levels of mortality [14,19,32-34].
Research continues into indicators such as preventable
and amenable mortality in order to evaluate quality, ac-
cess, and equity in the healthcare system [9,35-37]. It isalso necessary to continue identifying the areas of great-
est risk owing to these causes of death in urban areas of
large cities, where a large part of the population is con-
centrated, in order to carry out specific actions and re-
duce inequalities in mortality. In Spain, to date, there
have been no studies conducted to ascertain the evolu-
tion of amenable avoidable mortality and its association
with socioeconomic status in small areas of large cities.
The objective of this study is to analyse the temporal
evolution of amenable mortality between 1996 and 2007
and its association with socioeconomic status in small
areas (census tracts) of the three largest cities, province
capitals, of the Comunitat Valenciana (Spain): Alicante,
Castellón, and Valencia.Methods
This study was performed within the framework of the
MEDEA project [38,39]. This is a transversal ecological
study of amenable mortality in the cities of Alicante,
Castellón, and Valencia in the period (P) 1996–2007.
These cities are located on the south east coast of Spain
(Mediterranean coast), in the region of the Comunitat
Valenciana (CV). All the deaths corresponded to non-
institutionalised individuals residing in these three cities
during the study period. The deaths were georeferenced
by census tract and were obtained from databases used
with permission of the CV Death Register Office. The
causes of death between 1996 and 1998 were encoded in
accordance with the International Classification of Diseases,
9th Version (ICD-9), and the deaths that took place be-
tween 1999 and 2007 were classified using the 10th version
(ICD-10).
The causes of amenable deaths analysed in the study
were those proposed by Nolte and McKee, see Table 1,
and following the criterion defined by these authors,
only 50% of the deaths due to Ischaemic Heart Disease
were included [7,11].
The unit of analysis for each city was the Census Tract
(CT). CT urban structure of the cities belonging to 2001
was used. According to the population census for the
year 2001, the city of Alicante had 284,580 inhabitants,
Castellón 147,667, and Valencia 737,219. The number of
CTs studied were 215 for Alicante, 95 in Castellón, and
553 in Valencia. The average population size for the CTs
studied was 1355 inhabitants.
In each city, the socioeconomic status (SES) of each
CT was established using the following indicators (in
percentages):Unemployed
Percentage of people aged 16 or over without work (un-
employed and those looking for work for the first time),
in relation to the total active population.
Table 1 Frequencies and percentages (by city and sex), classification codes ICD-9 and ICD-10, and age range for the
amenable causes studied
CAUSE ICD-9 ICD-10 AGE Sex Alicante Castellón Valencia
n % n % n %
1 Intestinal infections M 0 0.0 1 0.1 2 0.0
002-009 A00-A09 0-14 F 0 0.0 0 0.0 0 0.0
2 Tuberculosis 010-018, A15-A19, M 25 1.6 11 1.4 41 0.9
137 B90 0-74 F 4 0.3 4 0.6 12 0.3
3 Other infections (diphtheria, tetanus, poliomyelitis) 032 A36, A35, M 0 0.0 0 0.0 2 0.0
037, 045 A80 0-74 F 0 0.0 0 0.0 0 0.0
4 Whooping cough M 0 0.0 0 0.0 0 0.0
033 A37 0-14 F 0 0.0 0 0.0 0 0.0
5 Septicaemia M 58 3.7 13 1.7 115 2.5
038 A40-A41 0-74 F 22 1.8 9 1.4 70 2.0
6 Measles M 0 0.0 0 0.0 0 0.0
055 B05 1-14 F 0 0.0 0 0.0 0 0.0
7 Malignant neoplasm of colon and rectum M 269 17.3 144 18.8 846 18.7
153-154 C18-C21 0-74 F 201 16.2 114 18.1 508 14.4
8 Malignant neoplasm of skin M 3 0.2 0 0.0 14 0.3
173 C44 0-74 F 3 0.2 1 0.2 4 0.1
9 Malignant neoplasm of breast M 2 0.1 0 0.0 4 0.1
174 C50 0-74 F 317 25.5 140 22.2 950 26.9
10 Malignant neoplasm of cervix uteri M 0 0.0 0 0.0 0 0.0
180 C53 0-74 F 38 3.1 21 3.3 118 3.3
11 Malignant neoplasm of cervix uteri and body uterus M 0 0.0 0 0.0 0 0.0
179, 182 C54-C55 0-44 F 2 0.2 0 0.0 4 0.1
12 Malignant neoplasm of testis M 3 0.2 1 0.1 7 0.2
186 C62 0-74 F 0 0.0 0 0.0 0 0.0
13 Hodgkin’s disease M 6 0.4 3 0.4 13 0.3
201 C81 0-74 F 2 0.2 4 0.6 18 0.5
14 Leukaemia M 12 0.8 10 1.3 50 1.1
204-208 C91-C95 0-44 F 11 0.9 5 0.8 23 0.7
15 Diseases of the thyroid M 3 0.2 1 0.1 1 0.0
240-246 E00-E07 0-74 F 6 0.5 1 0.2 13 0.4
16 Diabetes M 7 0.5 5 0.7 19 0.4
250 E10-E14 0-49 F 2 0.2 1 0.2 6 0.2
17 Epilepsy M 8 0.5 4 0.5 22 0.5
345 G40-G41 0-74 F 4 0.3 3 0.5 21 0.6
18 Chronic rheumatic heart disease M 21 1.4 10 1.3 70 1.5
393-398 I05-I09 0-74 F 36 2.9 34 5.4 148 4.2
19 Hypertensive disease I10-I13, M 37 2.4 23 3.0 99 2.2
401-405 I15 0-74 F 31 2.5 20 3.2 89 2.5
20 Ischaemic heart disease: 50% of deaths M 510 32.9 234 30.6 1366 30.2
410-414 I20-I25 0-74 F 185 14.9 79 12.5 394 11.2
21 Cerebrovascular diseases M 352 22.7 205 26.8 1059 23.4
430-438 I60-I69 0-74 F 238 19.2 116 18.4 719 20.4
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Table 1 Frequencies and percentages (by city and sex), classification codes ICD-9 and ICD-10, and age range for the
amenable causes studied (Continued)
22 All respiratory diseases 460-479, J00-J09, M 0 0.0 1 0.1 3 0.1
488-519 J20-J99 1-14 F 0 0.0 0 0.0 3 0.1
23 Influenza M 0 0.0 0 0.0 2 0.0
487 J10-J11 0-74 F 0 0.0 0 0.0 7 0.2
24 Pneumonia M 84 5.4 35 4.6 351 7.8
480-486 J12-J18 0-74 F 34 2.7 17 2.7 157 4.4
25 Peptic ulcer M 24 1.5 6 0.8 48 1.1
531-533 K25-K27 0-74 F 7 0.6 4 0.6 13 0.4
26 Appendicitis M 1 0.1 2 0.3 8 0.2
540-543 K35-K38 0-74 F 1 0.1 1 0.2 4 0.1
27 Abdominal hernia M 1 0.1 3 0.4 8 0.2
550-553 K40-K46 0-74 F 1 0.1 3 0.5 15 0.4
28 Cholelithiasis and cholecystitis M 8 0.5 9 1.2 30 0.7
574-575.1 K80-K81 0-74 F 6 0.5 5 0.8 22 0.6
29 Nephritis and nephrosis N00-N07, M 66 4.3 22 2.9 188 4.2
580-589 N17-N19, N25-N27 0-74 F 46 3.7 21 3.3 97 2.7
30 Benign prostatic hyperplasia M 1 0.1 0 0.0 2 0.0
600 N40 0-74 F 0 0.0 0 0.0 0 0.0
31 Maternal death M 0 0.0 0 0.0 0 0.0
630-676 O00-O99 All F 2 0.2 0 0.0 3 0.1
32 Congenital cardiovascular anomalies M 15 1.0 9 1.2 52 1.1
745-747 Q20-Q28 0-74 F 15 1.2 9 1.4 39 1.1
33 Perinatal deaths P00-P96, M 34 2.2 12 1.6 101 2.2
760-779 A33, A34 All F 26 2.1 17 2.7 72 2.0
34 Misadventures to patients E870-E876, Y60-Y69, M 1 0.1 0 0.0 4 0.1
E878-E879 Y83-Y84 All F 2 0.2 1 0.2 2 0.1
TOTAL AMENABLE M 1551 100.0 764 100.0 4527 100.0
F 1242 100.0 630 100.0 3531 100.0
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Percentage of people aged 16 or over who, according to
the lists from the National Institute of Statistics, cannot
read or write, or can read and write but have fewer than
5 years’ schooling, or went to school for 5 or more years
but did not complete their primary studies, in relation to
the total population aged 16 or over.Low level of education among young people
Percentage of people aged 16 to 29 with a low level of
education in relation to the total population aged 16 to 29.Manual workers
Percentage of people aged 16 or over who have a manual
job (employees in the following sectors: services,
agriculture, fishing, artisan work, specialist workers in
manufacturing industries, construction, mining, installationoperators, and non-specialist workers) in relation to the
total number of people aged 16 or over in employment.
Temporary workers
Percentage of people aged 16 or over in temporary em-
ployment (part-time self-employed workers, temporary
workers), in relation to the total number of people aged
16 or over in employment.
These indicators were used previously in the MEDEA
project. Their capacity to classify census tracts by so-
cioeconomic status has been demonstrated in a prior
study [34]. On the basis of these indicators, three levels
were selected for the SES: SES1 (most privileged socio-
economic status) includes all CTs with values below
the 25th percentile in the 5 indicators, SES3 (least pri-
vileged socioeconomic status) represents all CTs with
values above the 75th percentile; the remaining CTs
were included in SES2 (intermediate socioeconomic
Nolasco et al. BMC Public Health 2014, 14:299 Page 5 of 12
http://www.biomedcentral.com/1471-2458/14/299status). The databases of indicators were freely avail-
able and were obtained from the Population and Hous-
ing Census - 2001 of the Spanish National Statistics
Institute.
Table 2 shows the distribution of CTs and population
by SES. Figure 1 shows the geographical distribution of
the CTs by SES for the three cities studied.
The populations by CT, age and sex used to calculate
mortality indices for the years studied were obtained with
permission from the Register Office of the Valencian
Institute of Statistics, which is responsible for compiling
population statistics in this region.
To study the evolution of the risk of death over time, the
data were classified into three time periods: 1996–1999
(P1), 2000–2003 (P2), and 2004–2007 (P3). Deaths were
also grouped by age range: 0–49, 50–64, and 65–74 years
of age.
The number and percentage of deaths were calcu-
lated for each cause, by sex, period, and city, along with
the specific mortality rates (per 100,000 inhabitants).
Age Standardised Rates (ASR) have been calculated for
each city, sex, period, and SES, using the Spanish
population of 2001 as the standard population. Poisson
regression models were adjusted using the logarithm of
the death rate to estimate the Relative Risks (RR) of
death, and their corresponding intervals of confidence at
95%, for each level of the explanatory variables SES,
period, and age group [40]. Interaction between SES and
period, SES and age group, and age group and period
was studied. Possible overdispersion of the models was
controlled [41]. The statistical software package R ver-
sion 2.12.2 was used for analysis. All the analyses were
separated by sex.Table 2 Number of Census Tracts (CTs) and population of 200
death due to amenable mortality (AM) in comparison to tota
CITY SES1 SES2 SES3 TYPE MORTAL
CTs Pop CTs Pop CTs Pop
Alicante 15 21404 180 218224 20 22856 AM
TM
Castellón 6 10266 84 118144 5 8418 AM
TM
Valencia 53 62859 456 576146 44 49370 AM
TMEthical review
All data used in the analysis have been routinely collected
by government statistical agencies, and were anonymized
before they were supplied to us. Under these conditions,
national regulations do not require ethical review of study
proposals.
Results
Amenable mortality represents approximately 10% of total
mortality, for men and women, and for the three cities
studied (Table 2). Among men, there were 1551 deaths in
Alicante, 764 in Castellón and 4527 in Valencia. Among
women, there were 1242, 630, and 3531 deaths in each city,
respectively.
By time periods, for the three cities studied, there is a
slight decline in amenable mortality from 12% in the
first period to 10% in the third period, approximately
(Table 2).
The most frequent cause of amenable mortality with
regard to the total for amenable causes was ischaemic
heart disease (IHD) for men, with 32.9% in Alicante,
30.7% in Castellón, and 30.2% in Valencia (Table 1).
Among women, the most frequent cause of death was
breast tumour, representing 22.2%, 19.7% and 26.9%
in each city, respectively. The second most frequent
amenable cause among men and women was cerebro-
vascular diseases in the three cities, with percentages
between 17% and 23% among men, and 16% and 20%
among women.
Table 3 shows the specific rates of amenable mortal-
ity by sex, period, and age. In overall, the specific rates
of amenable mortality are higher in the least privileged
group in the three periods, but there are some exceptions1 (Pop) by SES level, and frequencies and percentages of
l mortality (TM), by sex, period, and city
SEX 1996-99 2000-03 2004-07 1996-2007
n % n % n % n %
M 551 11.8 525 10.7 475 9.8 1551 10.7
F 471 11.6 393 9.5 378 8.7 1242 9.9
M 4682 100.0 4893 100.0 4854 100.0 14429 100.0
F 4046 100.0 4158 100.0 4366 100.0 12570 100.0
M 304 12.0 220 8.5 240 9.3 764 9.9
F 230 10.9 191 8.6 209 9.3 630 9.6
M 2542 100.0 2598 100.0 2583 100.0 7723 100.0
F 2107 100.0 2232 100.0 2253 100.0 6592 100.0
M 1693 11.6 1502 10.6 1332 9.6 4527 10.6
F 1351 10.3 1155 8.7 1025 7.4 3531 8.8
M 14578 100.0 14109 100.0 13931 100.0 42618 100.0






Figure 1 Geographical distribution of the Socioeconomic Status (SES) according to census tracts in Alicante, Castellón and Valencia.
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evaluated globally. Figure 2 shows the evolution of the ASR
(logASR) by SES level for each city, and sex. As can be ob-
served, there is a decrease of the ASR from the first period
to the last one, with differences depending on city and sex,
in all cases, except for SES1 in Castellón for women. For
men, the decrease of the ASR was slightly higher in SES1 in
Alicante and higher in SES3 in Castellón and Valencia. The
distance between SES1 and SES3 increased from the first
period to the last one only in Alicante, and decreased the
most in Castellón. For women, the decrease in the ASR
was similar in SES1 and SES3 in Alicante and Valencia,
whereas they decreased in SES3 and slightly increased in
SES1 in Castellón. The distances between SES1 and SES3
were very similar in the first and last period, slightly lower
in the last period in Castellón.
Table 4 shows the Relative Risks (RR) of death and
their confidence intervals at 95% obtained using Poisson
regression models with explanatory variables SES, age,
and period. It cannot be stated that inequalities in the
risks of death according to SES have changed signifi-
cantly over the time periods studied, since there is no
significant interaction between SES and period in any of
the cases studied. For men, in Alicante, the risk of death
is 1.5 (1.1-1.9) times higher when they are in the most
underprivileged group SES3 in comparison with SES1,
and the risk of death decreases in the third period
in comparison with the first, RR = 0.8 (0.7-0.9). In
Castellón, the risk of death decreases in P2 and P3 in
comparison with P1. In this city, differences due to SES are
not significant among men, although the values for relativerisk among SES levels are similar to those obtained in the
other two cities. In Valencia, the relative risk of death is 0.8
(0.7-0.8) in P3 and 0.9 (0.8-0.9) in P2 in comparison with
P1, and the risk of death is 1.4 (1.2-1.6) times higher in
SES3 than in SES1.
Among women, in the three cities, the risk of death
decreases in P2 and P3 in comparison to P1. By SES, the
risk of death in SES3 is 1.8 (1.3-2.4) times higher than
for SES1 in Alicante, and 1.7 (1.1-2.6) times higher in
Castellón. In Valencia, this risk is 1.8 (1.3-2.4) times
higher in the 50–64 age group and 1.5 (1.2-1.8) times
higher in the 65–74 age range, since there is a significant
interaction between SES and age group.
Discussion
Using data from three major Spanish cities, basic socio-
economic indicators of the educational and working
environment have been used in this study to examine
socioeconomic inequalities in amenable mortality and
thus evaluate equity in the effectiveness of the health
service. The existence of inequalities in amenable mor-
tality should highlight the differences in the result of
healthcare provision between groups from different so-
cioeconomic status. Consideration of a cause of death as
amenable was based on the existence of effective inter-
ventions to prevent it. The results of this study show
that amenable mortality makes a significant contribution
to general mortality (around 10%, higher among men),
having decreased over time in the three cities studied for
men and women. Results are consistent, since in the
three cities studied the risks of death are higher in areas
Figure 2 Evolution of Age Standardised Rate (Log(ARS)) by socioeconomic status (SES), city, and sex.
Table 3 Specific rates (x100.000) of amenable mortality by sex, period, age, socioeconomic status level (SES), and city
MALE
Period (years) ALICANTE CASTELLÓN VALENCIA
0-49 50-64 65-74 0-49 50-64 65-74 0-49 50-64 65-74
1996-99 SES1 13,1 131,4 717,7 24,4 112,1 420,2 19,1 162,2 568,6
SES2 24,8 171,4 730,5 22,5 209,5 832,4 23,3 223,9 781,9
SES3 13,4 214,4 877,8 8,0 272,6 881,5 33,2 259,9 819,7
2000-03 SES1 12,7 108,2 624,3 6,2 175,5 493,9 20,6 136,1 614,3
SES2 17,5 162,0 680,2 15,6 115,6 575,7 21,7 177,7 673,8
SES3 28,2 185,9 667,7 23,5 167,7 687,8 36,6 189,6 754,3
2004-07 SES1 9,9 80,4 437,4 17,1 64,5 482,2 23,1 121,2 550,8
SES2 16,7 140,4 564,8 18,0 145,3 560,1 19,9 155,9 570,1
SES3 23,7 223,7 583,4 18,0 247,0 257,1 26,6 267,8 565,7
FEMALE
Period (years) ALICANTE CASTELLÓN VALENCIA
0-49 50-64 65-74 0-49 50-64 65-74 0-49 50-64 65-74
1996-99 SES1 22,2 121,3 205,6 6,6 109,6 411,2 22,1 85,1 304,9
SES2 20,9 145,1 466,1 19,5 133,6 496,0 25,0 141,1 448,5
SES3 17,1 179,7 518,2 32,3 235,1 738,5 16,1 192,4 494,1
2000-03 SES1 9,1 50,0 361,0 18,0 89,2 252,3 27,4 105,0 342,1
SES2 15,7 118,3 346,1 18,0 125,7 336,5 22,6 110,4 355,2
SES3 27,9 121,9 613,6 16,2 182,0 462,2 18,0 175,5 468,3
2004-07 SES1 22,0 71,6 182,3 19,3 53,4 485,7 10,8 82,9 283,0
SES2 15,3 117,4 316,9 19,0 100,3 388,2 20,5 110,5 306,5
SES3 22,6 158,2 332,8 30,8 84,6 643,2 17,6 113,1 403,9
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Table 4 Adjusted Relative Risks (RR) of death and
confidence intervals at 95% for age, period, and
socioeconomic status, according to city and sex
RR of death - CI at 95% (*)
MEN WOMEN
ALICANTE
Age 00-49 1 1
50-64 8.2 (7.0-9.7) 7.1 (6.0-8.4)
65-74 34.2 (29.6-39.5) 21.1 (18.1-24.7)
Period 96-99 1 1
00-03 0.9 (0.8-1.0) 0.8 (0.7-0.9)
04-07 0.8 (0.7-0.9) 0.7 (0.6-0.8)
SES SES1 1 1
SES2 1.3 (1.0-1.6) 1.4 (1.1-1.8)
SES3 1.5 (1.1-1.9) 1.8 (1.3-2.4)
CASTELLÓN
Age 00-49 1 1
50-64 8.4 (6.7-10.5) 6.3 (5.0-7.9)
65-74 34.2 (27.9-41.9) 21.9 (17.8-27.0)
Period 96-99 1 1
00-03 0.7 (0.6-0.8) 0.8 (0.6-0.9)
04-07 0.7 (0.6-0.8) 0.8 (0.7-0.9)
SES SES1 1 1
SES2 1.3 (0.9-1.7) 1.1 (0.8-1.6)
SES3 1.4 (0.9-2.1) 1.7 (1.1-2.6)
VALENCIA
Age 00-49 1
50-64 8.3 (7.6-9.1) (**)
65-74 29.8 (27.4-32.4)
Period 96-99 1 1
00-03 0.9 (0.8-0.9) 0.8 (0.8-0.9)
04-07 0.8 (0.7-0.8) 0.7 (0.7-0.8)
SES SES1 1
SES2 1.2 (1.1-1.3) (**)
SES3 1.4 (1.2-1.6)
(**) 00-49 SES1 1
SES2 1.1 (0.9-1.5)
SES3 0.9 (0.6-1.3)
(**) 50-64 SES1 1
SES2 1.3 (1.0-1.6)
SES3 1.8 (1.3-2.4)
(**) 65-74 SES1 1
SES2 1.2 (1.0-1.4)
SES3 1.5 (1.2-1.8)
(*) In bold, RR are statistically significant at 95%.
(**) Owing to the existence of significant interaction between age and SES for
women, the RRs for the SES are shown in each of the age groups.
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over time.
The percentage of amenable deaths with regard to gen-
eral mortality has been decreasing over the three study pe-
riods, for men and women, in the three cities studied. The
decrease observed for amenable mortality over time agrees
with the results obtained in other studies suggesting that
improvements in health services have contributed signifi-
cantly to the improvement of the population’s health in
recent years [11,18,19,23,26,28,42]. The decreasing trend
in amenable mortality found in this study is similar to
that found for preventable mortality in Spain in other
studies [43,44].
The socioeconomic inequalities found are along the
same lines as those observed in other studies. For ex-
ample, Tobias and Yeh found that amenable causes
make an important contribution to the mortality differ-
entials between socio-economic groups in New Zealand,
with data from 1981–84 and 2001–04 [8]. Furthermore,
Nagy, et al., examining data from 2004 to 2008, found a
relationship between the risks of death due to amenable
causes and deprivation in geographical areas of Hungary
[22]. Schoenbaum, et al. provided evidence of excessive
amenable mortality in areas with higher populations of
poor and black people in the US in 2005 [21]. In the city
of New York, Althoff, et al. found that disparities in the
mortality due to several amenable causes of poor and
wealthy have not narrowed between 1989–91 and 1999–
2001 [45]. Using data from 14 European countries (in-
cluding Spain for the city of Barcelona and the regions
of Madrid and the Basque Country), Plug, et al. observed
the presence of inequalities in amenable mortality re-
garding level of education [44].
In relation to the evolution of socioeconomic inequal-
ities over time, this study does not find evidence of
modification between the periods studied with regard to
inequalities between socioeconomic status levels in any
of the three cities, since the effects of interaction be-
tween SES and the study period were not significant,
possibly indicating that inequalities have remained con-
stant in both periods. This result coincides with the find-
ings of some studies but counters the results of others.
Korda, et al., looking at small areas of Australia, observed
that amenable mortality decreased significantly but more so
among the highest levels of SES between 1986 and 2002
[18]. James, et al. observed a reduction in socioeconomic
differences in amenable mortality in Canada between 1971
and 1996, maintaining significant inequalities [26]. In
Finland, Lumme, et al. observed, using data from 1992 to
2008, that in spite of the decrease in amenable mortality
rates, socioeconomic differences have increased, coincid-
ing with the findings of McCallum, et al. for that same
country [23,30]. In Canada, James, et al. found a signifi-
cant decrease in socioeconomic inequalities in amenable
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this was not the same for preventable mortality owing to
public health policies [19].
The findings of this study can be compared with those
obtained by the authors in a previous study conducted
on the same cities, with the same socioeconomic indicators,
census tracts, and a similar methodology to estimate socio-
economic inequalities in preventable avoidable mortality
with data from 1996 to 2003 [34]. In that research, higher
risks of death were found owing to causes of preventable
mortality in the most underprivileged areas, but they were
greater than those obtained here for amenable mortality
among men (relative risks above 2 in the three cities), and
lower among women (only the city of Valencia presented a
value significantly higher than 1). However, the results ob-
tained from this study point to excesses in the risk of death
in areas with a lower socioeconomic status that are similar
among men and women, and in all three cities, suggesting
that the effect of socioeconomic inequalities on amenable
mortality is more homogenous than on preventable mortal-
ity. The interaction detected between the effect of SES and
the effect of age among women in the city of Valencia nu-
ances the interpretation of excess mortality among more
under privileged SES levels, establishing a significant excess
risk only among older women (>50 years of age).
In relation to the classification by SES used in this
work, it is worth mentioning that the relative risks esti-
mated between the most and least privileged categories
represent the relative risk between the worst and best-
off population group in all the indicators used. Hence,
the interpretation of these relative risks differs from that
obtained using other classifications based on percentiles
or on the continuous value of a compound socioeco-
nomic indicator based on the originals, and indicates the
level of extreme inequalities, between categories that can be
identified as being of maximum and minimum deprivation.
This classification identifies areas of maximum deprivation,
susceptible to greater vigilance and attention.
The most common cause of amenable mortality in
this study for men was ischaemic heart disease, al-
though only 50% of deaths were included, which was
also the third most frequent cause of death for women.
In a recent study conducted in small areas of nine
major cities in Spain, a decrease in mortality owing to
this cause was found over time in small areas of
Spanish cities between 1996 and 2007, coinciding with
the decrease in amenable mortality found here [46].
The socioeconomic inequalities found in this study for
this cause were greater among women than among
men, which cannot be firmly asserted for amenable
mortality studied as a whole in this article since, al-
though the relative risks of death estimated between
levels of SES are slightly higher among women, they do
not present significant differences with men, whichsuggests the socioeconomic inequalities in amenable
mortality are similar in the two sexes.
Amenable mortality has been used for decades to as-
sess health care delivery. Recent studies have confirmed
that such indicator is useful to establish the impact of
health care innovation on population’s health. However,
they suggest that amenable mortality should be inter-
preted with caution when being used as an indicator of
health care performance, especially when comparing dif-
ferent countries, for this indicator may reflect the influ-
ence of health care and other factors [36,47,48]. Our
study confirms, on the one hand, the idea that amenable
mortality is related not only to health care delivery but
also to other factors. Socioeconomic inequalities found
show not only an unequal health care delivery but also
many other unequal socioeconomic factors that influ-
ence mortality. On the other hand, this study has been
performed in urban areas, where the overall population
has health insurance and medical coverage. Furthermore,
the three cities have a common health care policy frame-
work, and hence, the innovations and improvements
were introduced at the same time for the whole population.
These conditions suggest that health care delivery may have
an independent effect on amenable mortality, which may
not confound the effect of other factors that belong to
socioeconomic status because of the conditions described
above (overall medical coverage and health insurance,
urban areas, similar policy framework…), which make it dif-
ficult to think about an association between socioeconomic
factors and health care delivery. These conditions are differ-
ent to the ones in the study of Shoenbaum et al., carried
out on United States population with different health
insurance and medical coverage. This study described
the association between amenable mortality and indi-
cators related to both health care and socioeconomic
factors, and concluded that it is important to adjust
the effect of one on the other [21].
The causes of inequality observed between socioeco-
nomic status levels can be complex.
On the one hand, the differences found might pertain
to different access to and quality of healthcare according
to SES, as suggested in various studies, so that higher in-
come population segments are more likely to see a spe-
cialist [49,50]. However, other studies have not found
any links between inequalities in the use of healthcare and
amenable mortality [44]. On the other, the prevalence, inci-
dence, and natural course of some diseases might have an
effect on amenable mortality and differ between socioeco-
nomic groups, since the exposure to its risk factors might
also differ. Survival following treatment might also be af-
fected by different resources according to socioeconomic
status (social support, resources at home, medical insur-
ance, etc.). These possible differences have not been taken
into account in this study. Regardless of accessibility and
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be related with their level of culture, and can influence as-
pects such as self-care, and access to information about the
health-disease process, factors that influence the way in
which healthcare services are accessed and used. Hence, for
many amenable causes, there is access to healthcare
services but they are not used in the early stages of
the diseases; people reach the healthcare system when
their condition has worsened, and there might be a
direct influence between the patient’s trajectory of self-
care and mortality.
This study was conducted during a period in which
the Spanish Healthcare System offers universal and free
access to all citizens, differentiating it from other coun-
tries where this is not the case. This starting point is
favourable to reducing mortality and to achieve equity
but does not guarantee it, as shown by the results of this
and other studies [37,51,52].
This study presents certain limitations. Firstly, it is an
ecological study, with all the limitations this kind of
study brings. Thus, it does not allow the proof of a
causal association. The association found between SES
and mortality using CTs may not be applicable at an in-
dividual level (i.e. ecological fallacy). With reference to
the causes analysed, the list used could have differed.
The choice of these causes responded to a criterion of
comparability with many other studies. The consistency
of the results obtained indicates that they would not
have been substantially different from those obtained
using a different list with minor variations. Hence, the
inclusion of 50% of deaths due to ischaemic heart dis-
ease was revised, recalculating the relative risks between
levels of SES with 100% of deaths, but no substantial
variations were found in the estimations. Another limita-
tion could pertain to the use of different classifications
of mortality over the period of study, which were felt to
be minimal, given the experience of the encoding team
from the Death Register Office, which was the same
throughout the period of study. The classification of
census tracts by SES was carried out using accumulated
data from the 2001 census and was the same for the
entire period of study. The year 2001 is right in the
middle of the study period and it was thought that
there would not be substantial variations over the
course of this period. Another aspect to consider is
that avoidable mortality only takes account of deaths
and no other health results, offering an incomplete
vision of the benefits of healthcare. Furthermore, as
mentioned previously, the causes of socioeconomic
differences in amenable mortality can come from a
complex model in which differences in the prevalence
or incidence of diseases are involved, along with differ-
ences in pre and post treatment resources, and even
biases in access to and quality of healthcare.Inequalities in health, and specifically the differences
reflected in amenable mortality, which emerge between
the least and the more privileged groups in the popula-
tion, is undoubtedly one of the greatest challenges faced
by healthcare policies and modern healthcare systems.
The differences in avoidable mortality, preventable or
amenable, are usually the reflection of an unequal sys-
tem, and their analysis is essential in order to under-
stand in detail the weaknesses of the system, and to take
effective actions.
The period studied in this article concludes in 2007,
coinciding with the start of the current global economic
crisis that is having such a major effect on Spain. As
such, this work could provide a point of reference for fu-
ture studies that assess the evolution of inequalities in
subsequent periods.
Conclusions
This study consistently highlights that, although amen-
able mortality decreases over time, its socioeconomic in-
equalities are maintained in the three cities. Areas have
been identified that show excesses in amenable mortal-
ity, potentially attributable to deficiencies in the health-
care system, and associated with low socioeconomic
level. These are the higher risk areas where action must
be taken to reduce inequalities in health detected. It is
necessary, therefore, to study in depth the causes of so-
cioeconomic inequalities in amenable mortality.
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